Constellation’s shares rose modestly by 1.8% post-earnings, reflecting a solid quarter with an increased guidance update but arguably without the momentum to push the stock higher amid ongoing regulatory uncertainties and a multi-year timeline for key project restarts.
- Reported second quarter GAAP earnings of $1.42 per share and adjusted operating earnings of $2.55 per share.
- Increased full-year adjusted operating earnings guidance by $0.50 to a range of $11.50 to $12.50 per share, with the midpoint now at the previous high end of guidance.
- Signed approximately 920 megawatts of long-term nuclear contracts averaging 18.5 years with investment-grade customers, indicating progress in commercial execution.
- Regulatory progress includes NRC approval of new fuel licensing for the Crane facility restart, expected in the second half of 2027, and FERC approval to transfer capacity injection rights from Eddystone to Crane.
- Ongoing regulatory uncertainty and extended timelines for key asset restarts temper enthusiasm despite operational achievements and long-term contract wins.
Community Discussion